Skip to content
Screener

Artivion AORT Treasury stock, shares (in shares)

Treasury stock, shares (in shares) at other companies

LivaNova logo
LivaNovaLIVN
$549.38K-39.5%
ICU Medical logo
ICU MedicalICUI
$179.64K+417,660%
Edwards Lifesciences logo
Edwards LifesciencesEW
ITG
Integer HoldingsITGR
Boston Scientific logo
Boston ScientificBSX
AngioDynamics logo
AngioDynamicsANGO

Other financials

Income statement

See full
Revenue$125.8M+11.3%
Gross profit$80.5M+10.1%
Operating income-$8.4M-200%
Net income-$13.5M-1,104%
EPS (diluted)-$0.28-1,033%

Balance sheet

See full
Cash & equivalents$77.3M+44.6%
Total debt$408.0M+54.7%
Total equity$445.6M+6.1%
Total assets$1.1B+27.9%

Cash flow

See full
Operating cash flow-$1.3M-108%
CapEx$10.7M+227%
Free cash flow-$12.0M

Valuation

See full
Market cap$1.28B-33.5%
Enterprise value$1.61B-24.6%
P/S2.7×-2.0×

Profitability

See full
Gross margin64.4%+0.4pp
Operating margin4.4%0.0pp
Net margin-0.7%-0.3pp
FCF margin-0.1%-2.5pp

Returns & leverage

See full
Return on equity-0.7%-0.3pp
Debt / equity0.9×+0.3×
Current ratio3.5×-1.3×

Where this comes from

Reported directly by Artivion in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.

The source filing: Artivion’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 1:57 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054746
Line itemJune 30,2026December 31,2025
Preferred stock $0.01 par value per share, 5,000 shares authorized, no shares issued
Common stock $0.01 par value per share, 75,000 shares authorized, 50,179 and 49,330 shares issued as of June 30, 2026 and December 31, 2025, respectively502493
Additional paid-in capital535,798516,604
Retained deficit(63,591)(51,498)
Accumulated other comprehensive loss(12,476)(2,719)
Treasury stock, at cost, 1,487 shares as of June 30, 2026 and December 31, 2025(14,648)(14,648)
Total stockholders’ equity445,585448,232
Total liabilities and stockholders’ equity$1,071,934$884,796

Item 1. Financial Statements.

FAQ

What is Artivion's treasury stock, shares (in shares)?
Artivion (AORT) reported treasury stock, shares (in shares) of $1.49M in Q2 2026.
How has Artivion's treasury stock, shares (in shares) changed year-over-year?
Artivion's treasury stock, shares (in shares) decreased by 0.0% year-over-year, from $1.49M to $1.49M.
What is the long-term trend for Artivion's treasury stock, shares (in shares)?
Over 5 years (2020 to 2025), Artivion's treasury stock, shares (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $1.49M to $1.49M.
What does treasury stock, shares (in shares) mean?
Treasury stock, shares (in shares)

Ask your AI about Artivion's treasury stock, shares (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude